Interactive Breakout Discussions
FACILITATED, SMALL-GROUP DISCUSSIONS. INTERACTIVE PARTICIPATION LEADS TO PROBLEM-SOLVING SOLUTIONS AND FUTURE COLLABORATIONS AROUND FOCUSED TOPICS.
Join your colleagues and fellow delegates for a focused, informal discussion moderated by a member of our speaking faculty. A small group format allows participants to meet potential collaborators, share examples from their own work and discuss ideas with peers.
TUESDAY, 16 MARCH, 12.05pm - 12.25pm
Automation and Digitization for Process Development
Alan Baines, Director, Project Lead Testing Solutions, Lonza BioScience Solutions
Rob Lutskus, Associate Director, Lonza Global Informatics
- Productivity increases – data from aseptic sampling and automation case studies
- Improved data quality from automated sampling and automated data capture
- Quality and data integrity improvements from electronic batch records
- Automated data collection and removal of redundancies with paperless systems
Optimizing biopharma downstream processes: Enhance efficiencies and cost-effectively in downstream production
Willie Hesselink, Senior Technical Application Project Manager, Biopharma Production, Avantor
- Fields of improvement in DSP
- Chances and Challenges of Digitalization
- Current chromatography technologies
- Raw material handling strategies
- Process improvements in small-scale and big-scale manufacturing
WEDNESDAY, 17 MARCH, 10.15am - 10.45am
Technologies for the Future of Bioprocess Development: What Are They and How to Choose?
Moritz von Stosch, PhD, Chief Innovation Officer, Datahow, Switzerland
- What are the bioprocess (development) technologies of the future?
- How to focus effort on the most relevant technologies for bioprocess (development) of the future?
- Will our current business models still work?
- How do new modalities change the bioprocess (development) landscape?
DSP, Process Intensification and Digitalization
Alois Jungbauer, PhD, Professor & Head, Biotechnology, Institute of Bioprocess Science and Engineering, University of Natural Resources and Life Sciences (BOKU)
- Common DSP challenges
- Integrated continuous manufacturing
- Process control
- Digitalization
Gene Therapy CMC and Manufacturing
Christopher Bravery, PhD, Consulting Regulatory Scientist, Consulting on Advanced Biologicals Ltd.
Florence Salmon, PhD, Independent Consultant, Former, Director Regulatory Affairs CMC, Novartis Pharma AG
- Common Analytical Challenges for Viral Vectors
- Potency Assay Development
- Process Development and Scale-up
- Process Change and Comparability
Optimising Formulation Development for Novel Modalities, High and Low Concentration Protein Formulations, Combination Products and Co-Formulations
Paul Dalby, PhD, Professor, Biochemical Engineering, University College London, United Kingdom
- Rapid formulation of novel formats, eg. mRNA, viral vectors, exosomes
- New directions with established modalities, eg. mAbs
- Analytical advances and challenges
- How to handle the very low concentration products